Night blindness

References

Key articles

Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006 Nov 18;368(9549):1795-809. Abstract

Petzold A, Plant GT. Clinical disorders affecting mesopic vision. Ophthalmic Physiol Opt. 2006 May;26(3):326-41. Abstract

Goodwin P. Hereditary retinal disease. Curr Opin Ophthalmol. 2008 May;19(3):255-62. Abstract

Reference articles

1. Joshi D, Dhawan A, Baker AJ, et al. An atypical presentation of cystic fibrosis: a case report. J Med Case Reports. 2008 Jun 12;2:201.Full text  Abstract

2. Lee WB, Hamilton SM, Harris JD, et al. Ocular complications of hypovitaminosis A after bariatric surgery. Ophthalmology. 2005 Jun;112(6):1031-4. Abstract

3. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006 Nov 18;368(9549):1795-809. Abstract

4. Petzold A, Plant GT. Clinical disorders affecting mesopic vision. Ophthalmic Physiol Opt. 2006 May;26(3):326-41. Abstract

5. Khan N, Huang JJ, Foster CS. Cancer associated retinopathy (CAR): an autoimmune-mediated paraneoplastic syndrome. Semin Ophthalmol. 2006 Jul-Sep;21(3):135-41. Abstract

6. Goodwin P. Hereditary retinal disease. Curr Opin Ophthalmol. 2008 May;19(3):255-62. Abstract

7. Jayaram H, Downes SM. Midlife diagnosis of Refsum disease in siblings with retinitis pigmentosa--the footprint is the clue: a case report. J Med Case Reports. 2008 Mar 12;2:80.Full text  Abstract

8. McCauley ME, van den Broek N, Dou L, et al. Vitamin A supplementation during pregnancy for maternal and newborn outcomes. Cochrane Database Syst Rev. 2015 Oct 27;(10):CD008666.Full text  Abstract

9. Sommer A. Vitamin A deficiency and clinical disease: an historical overview. J Nutr. 2008 Oct;138(10):1835-9.Full text  Abstract

10. Law WC, Rando RR. The molecular basis of retinoic acid induced night blindness. Biochem Biophys Res Commun. 1989 Jun 15;161(2):825-9. Abstract

11. Potter MJ, Thirkill CE, Dam OM, et al. Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy. Ophthalmology. 1999 Nov;106(11):2121-5. Abstract

12. Javadzadeh A, Gharabaghi D. Gyrate atrophy of the choroid and retina with hyper-ornithinemia responsive to vitamin B6: a case report. J Med Case Reports. 2007 Jun 12;1:27.Full text  Abstract

13. Renner AB, Kellner U, Cropp E, et al. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram. Ophthalmology. 2006 Nov;113(11):2066.e1-10. Abstract

14. Radhika MS, Bhaskaram P, Balakrishna N, et al. Effects of Vitamin A deficiency during pregnancy on maternal and child health. BJOG. 2002 Jun;109(6):689-93. Abstract

15. Mayo-Wilson E, Imdad A, Herzer K, et al. Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis. BMJ. 2011 Aug 25;343:d5094.Full text  Abstract

16. Imdad A, Mayo-Wilson E, Herzer K, et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev. 2017 Mar 11;3:CD008524. Abstract

17. Alio JL, Pinero D, Muftuoglu O. Corneal wavefront-guided retreatments for significant night vision symptoms after myopic laser refractive surgery. Am J Ophthalmol. 2008 Jan;145(1):65-74. Abstract

18. McCulloch DL , Marmor MF, Brigell MG, et al. ISCEV standard for full-field clinical electroretinography (2015 update). Documenta Ophthalmologica. 2015 Feb;130(1):1-12.Full text  Abstract

19. Tanumihardjo SA. Assessing vitamin A status: past, present and future. J Nutr. 2004 Jan;134(1):290S-293S.Full text  Abstract

20. Charman WN. Night myopia and driving. Ophthalmic Physiol Opt. 1996 Nov;16(6):474-85. Abstract

21. Owsley C, Jackson GR, White M, et al. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 2001 Jul;108(7):1196-202. Abstract

22. Berson EL, Rosner B, Sandberg MA, et al. Vitamin A supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993 Nov;111(11):1456-9. Abstract

23. Massof RW, Fishman GA. How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa? Arch Ophthalmol. 2010 Apr;128(4):493-5. Abstract

24. Welsh BM, Smith AL, Elder JE, et al. Night blindness precipated by isotretinoin in the setting of hypovitaminosis A. Australas J Dermatol. 1999 Nov;40(4):208-10. Abstract

25. Russell S, Bennett J, Wellman JA, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet. 2017 Aug 26;390(10097):849-60.Full text  Abstract

26. Bainbridge JW, Mehat MS, Sundaram V, et al. Long-term effect of gene therapy on Leber's congenital amaurosis. N Engl J Med. 2015 May 14;372(20):1887-97.Full text  Abstract

27. Jacobson SG, Cideciyan AV, Roman AJ, et al. Improvement and decline in vision with gene therapy in childhood blindness. N Engl J Med. 2015 May 14;372(20):1920-6.Full text  Abstract

28. Bennett J, Wellman J, Marshall KA, et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet. 2016 Aug 13;388(10045):661-72.Full text  Abstract

29. MacLaren RE, Groppe M, Barnard AR, et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet. 2014 Mar 29;383(9923):1129-37.Full text  Abstract

30. Dimopoulos IS, Hoang SC, Radziwon A, et al. Two-year results after AAV2-mediated gene therapy for choroideremia: the Alberta experience. Am J Ophthalmol. 2018 Jun 27;193:130-42. Abstract

31. Berson EL, Rosner B, Sandberg MA, et al. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol. 2004 Sep;122(9):1297-305. Abstract

32. Hoffman DR, Locke KG, Wheaton DH, et al. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol. 2004 Apr;137(4):704-18. Abstract

33. Berson EL, Rosner B, Sandberg MA, et al. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol. 2004 Sep;122(9):1306-14. Abstract

34. Hoffman DR, Hughbanks-Wheaton DK, Pearson NS, et al. Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial. JAMA Ophthalmol. 2014 Jul;132(7):866-73.Full text  Abstract

Use of this content is subject to our disclaimer